Hosted on MSN1mon
EMA establish advisory portal for high-risk medical devicesThe European Medicines Agency (EMA), in collaboration with the European Commission (EC), has established a standard procedure for manufacturers of certain high-risk medical devices to request ...
17d
Pharmaceutical Technology on MSNEMA approves Takeda’s Takhzyro pre-filled pen option for HAEThe European Medicines Agency (EMA) has approved an additional 2 mL pre-filled pen option for subcutaneous administration of Takeda’s Takhzyro (lanadelumab), aimed at treating hereditary angioedema ...
The European Medicines Agency (EMA) said Monday it has established a way for manufacturers of certain high-risk medical devices to request scientific advice. Manufacturers of class III devices and ...
EMA, in close collaboration with the European Commission, has established a standard procedure for manufacturers of certain high-risk medical devices to request scientific advice on their intended ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results